Geode Capital Management’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$298K Sell
65,119
-2,445
-4% -$11.2K ﹤0.01% 3735
2025
Q1
$330K Buy
67,564
+994
+1% +$4.85K ﹤0.01% 3688
2024
Q4
$447K Buy
66,570
+3,879
+6% +$26.1K ﹤0.01% 3634
2024
Q3
$485K Buy
62,691
+8,168
+15% +$63.2K ﹤0.01% 3587
2024
Q2
$327K Sell
54,523
-82,846
-60% -$497K ﹤0.01% 3731
2024
Q1
$1.24M Buy
137,369
+1,904
+1% +$17.2K ﹤0.01% 3282
2023
Q4
$1.28M Buy
135,465
+6,203
+5% +$58.8K ﹤0.01% 3248
2023
Q3
$1.54M Buy
129,262
+5,586
+5% +$66.5K ﹤0.01% 3169
2023
Q2
$3.03M Buy
123,676
+20,180
+19% +$494K ﹤0.01% 2963
2023
Q1
$3.24M Buy
103,496
+5,807
+6% +$182K ﹤0.01% 2821
2022
Q4
$6.88M Buy
97,689
+3,599
+4% +$253K ﹤0.01% 2483
2022
Q3
$8.1M Buy
94,090
+16,479
+21% +$1.42M ﹤0.01% 2387
2022
Q2
$6.42M Buy
77,611
+10,188
+15% +$842K ﹤0.01% 2559
2022
Q1
$11.2M Buy
67,423
+5,616
+9% +$933K ﹤0.01% 2278
2021
Q4
$10.3M Buy
61,807
+1,339
+2% +$224K ﹤0.01% 2422
2021
Q3
$5.22M Buy
60,468
+3,122
+5% +$270K ﹤0.01% 2890
2021
Q2
$3.11M Buy
57,346
+6,113
+12% +$332K ﹤0.01% 3130
2021
Q1
$3.05M Buy
51,233
+4,182
+9% +$249K ﹤0.01% 3039
2020
Q4
$2.46M Buy
47,051
+4,145
+10% +$216K ﹤0.01% 2970
2020
Q3
$2.08M Buy
42,906
+1,006
+2% +$48.7K ﹤0.01% 2860
2020
Q2
$2.17M Sell
41,900
-352
-0.8% -$18.2K ﹤0.01% 2794
2020
Q1
$1.84M Buy
42,252
+29,307
+226% +$1.28M ﹤0.01% 2713
2019
Q4
$519K Buy
12,945
+386
+3% +$15.5K ﹤0.01% 3488
2019
Q3
$411K Buy
12,559
+467
+4% +$15.3K ﹤0.01% 3538
2019
Q2
$932K Buy
12,092
+2,714
+29% +$209K ﹤0.01% 3259
2019
Q1
$1.66M Buy
9,378
+3,573
+62% +$634K ﹤0.01% 2959
2018
Q4
$1.37M Buy
5,805
+3,244
+127% +$765K ﹤0.01% 2968
2018
Q3
$548K Buy
+2,561
New +$548K ﹤0.01% 3428